Who are you? Choose your path →

Who we serve · Pharma & clinical research

Enrollment, engineered with data.

Accelerating drug development with comprehensive data. Hagimo turns hundreds of millions of medical histories into feasibility, site selection and enrollment you can plan on.

Revolutionizing Clinical Trials: Harnessing the Power of AI and Big Data in Healthcare

What we offer you

Built for your work.

Clinical trials are part of our DNA. Since 2003 our team has applied data and analytics to the hardest problems in study design and enrollment.

  • Consulting

    Feasibility & simulations

    Lay your inclusion and exclusion criteria over more than 300 million health histories to project enrollment, attrition and incidence per site — before the study starts.

  • Consulting

    Data-driven site selection

    Place sites by proximity to eligible patients, referral patterns, media markets and centers of excellence — not by someone’s Rolodex.

  • Data

    Investigator database

    More than 250,000 principal and co-investigators, coordinators and site personnel, with contact information, NPI mapping and study-participation history.

  • Consulting

    Enrollment & outreach

    Direct provider and facility outreach, payer and TPA introductions, and data-driven advertising that reduces spend while increasing randomizations.

  • Coming soon

    Data Universe™ cohort analytics

    Build cohorts, fine-tune study parameters and run real-time analytics across patient, provider, facility and GIS dimensions with a subscription.

  • Product

    hLink™ for consent & intake

    AI guidance for patient intake, medical history questionnaires and clinical trial consent forms — simplifying terminology and ensuring completeness.

Proof

Two decades inside clinical research.

  • Since 2003Applying data aggregation and analytics to clinical trial challenges
  • 300M+Health histories available for study simulation
  • 250,000+Entries in our investigator database
  • 20 of 20Top pharmas our team has worked with

Industries: Clinical Trials

Compliance and Innovation in Clinical Trials

  • HIPAA Conformal: At Hagimo, we prioritize patient privacy and data security. All our processes and data handling are strictly HIPAA Conformal, ensuring the utmost protection of sensitive medical information.
  • Trial Feasibility and Simulations: Leveraging advanced analytics, we conduct comprehensive trial feasibility studies and simulations. This approach enables precise planning and informed decision-making, enhancing the success rates of clinical trials.
  • Data-Driven Clinical Site Selection: Our sophisticated data-driven methodology streamlines the selection of clinical sites. By analyzing a wealth of data, we identify optimal locations that align with trial requirements, boosting enrollment efficiency and trial effectiveness.
  • Support for Distributed Clinical Trials: Recognizing the evolving landscape of clinical research, we offer robust support for distributed clinical trials. Our services facilitate remote and decentralized trials, adapting to modern research needs and participant convenience.

Hagimo: Pioneering data intelligence in clinical trials for a healthier tomorrow.

Participant monitoring dashboard

In an era where over 400,000 clinical studies are actively shaping the future of healthcare (source: ClinicalTrials.gov Trends), the challenge of timely enrollment and retention in clinical trials has never been more critical. A staggering 70% of trials face delays or cancellations due to enrollment challenges, underscoring the need for innovative solutions. At Hagimo, we are at the forefront of transforming these challenges into opportunities for our pharmaceutical partners.

Leveraging our strategic partnerships with leading clearinghouses, EMR/EHR vendors, payers, and managed care plans, we've created a powerhouse of data integration. This synergy unlocks access to hundreds of millions of comprehensive medical histories, revolutionizing patient recruitment and study simulation. Our data-driven approach identifies clusters of eligible patients with precision. It also optimizes your advertising investments. Coupled with Hagimo's Clinical Study Team Network database (more than 200,000 medical professionals), Hagimo expertly places the right investigators in the right clinical sites, driving superior enrollment numbers and setting new industry standards.

Hagimo's unique data resources and physician network allow us to collaborate directly with providers, specialty groups, and health plans, ensuring that your study's information and enrollment materials are placed directly in the hands of suitable candidates. With our advanced analytics and targeted contact strategies, we ensure that every dollar of your recruitment budget is an investment in engaging the right participants efficiently and effectively.

Choose Hagimo to navigate the complexities of clinical trial execution with confidence and finesse. Our expertise is not just in gathering data, but in turning it into meaningful connections that accelerate your study timelines and contribute to groundbreaking healthcare advancements.

Selected clients

A trusted partner to the industry for over 20 years.

Our team has worked with all of the top 20 pharmas. Enterprise clients and projects have included:

  • Abbott Laboratories
  • Novartis AG
  • Medidata Solutions, Inc.
  • Shire (now part of Takeda Pharmaceutical Company)
  • Informa PLC
  • Clinerion Ltd
  • Medelis, Inc.
  • WPC Healthcare (Hayes)
  • eClinicalHealth
  • Citeline
  • Salix Pharmaceuticals, Ltd.
  • PPD Inc. (Pharmaceutical Product Development, LLC)
  • WCCT Global
  • Chiltern International Limited
  • Acurian, Inc.
  • SynteractHCR Holdings Corporation
  • MediciGlobal Ltd.
  • Pfizer Inc.
  • Veristat LLC
  • Icon PLC
  • WalMart
  • Symphony Health Solutions
  • Theorum LLC
  • Xcenda

For references and more information on these projects, please contact Hagimo Holdings. See the clinical trials story.

Next step

Know your study will enroll — before it starts.

Talk with us about feasibility, site selection, investigator targeting or data-driven enrollment for your next protocol.